Surg­ing US de­mand trig­gers new $2.9B pur­chase of Re­gen­eron's Covid-19 an­ti­bod­ies

Re­gen­eron has re­ceived a new $2.9 bil­lion or­der for its Covid-19 an­ti­body cock­tail as de­mand for mon­o­clon­al an­ti­bod­ies surges in the US amid a spike in cas­es.

The US gov­ern­ment is pur­chas­ing 1.4 mil­lion ad­di­tion­al dos­es of RE­GEN-COV, a com­bi­na­tion of casiriv­imab and imde­vimab, at a price of $2,100 for each 1,200mg dose — bring­ing the to­tal pur­chase to near­ly 3 mil­lion dos­es.

This marks the third sup­ply deal Re­gen­eron has scored in the US.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER